Logotype for Industrie De Nora S.p.A.

Industrie De Nora (DNR) Q3 2024 earnings summary

Event summary combining transcript, slides, and related documents.

Logotype for Industrie De Nora S.p.A.

Q3 2024 earnings summary

9 Jun, 2026

Executive summary

  • Revenues for the first nine months of 2024 reached €601.2 million, down 4.5% year-over-year, mainly due to a decline in Electrode Technologies and currency effects, while Water Technologies and Energy Transition segments showed growth or stability.

  • Adjusted EBITDA margin was 17.8% for 9M 2024, in line with guidance, reflecting a resilient business model despite a soft Q3 and increased R&D and ramp-up costs.

  • Net profit for 9M 2024 was €52.5 million, significantly lower than the prior year due to the absence of one-off gains from the tk nucera IPO.

  • The company maintained a strong net cash position of €29.7 million at September 30, 2024, supported by operating cash flow exceeding €80 million.

  • Strategic partnerships, new product launches, and ESG initiatives, including the Italian Gigafactory and Dragonfly electrolyzer, support long-term growth.

Financial highlights

  • Revenue for 9M 2024 was €601.2 million, down 4.5% year-over-year, with a negative FX impact, especially from the Japanese yen.

  • Adjusted EBITDA was €107.3 million (margin 17.8%), down from €122.0 million (19.4%) in 9M 2023, reflecting lower volumes and a different revenue mix.

  • Net income for 9M 2024 was €52.5 million, with a margin of 8.7%-9%.

  • Net cash position at September 2024 was €29.7 million, with operating cash flow of €81 million.

  • Basic and diluted EPS were €0.26, compared to €0.98 in the prior year.

Outlook and guidance

  • Full-year 2024 guidance confirmed: low single-digit group revenue growth, with Water Technologies and Energy Transition expected to grow and Electrode Technologies to remain broadly flat.

  • Adjusted EBITDA margin for the year expected at around 17%.

  • Q4 revenues are secured in the backlog and expected to drive a strong finish to the year.

  • Recovery in Electrode Technologies orders anticipated in Q4 and into 2025, especially in Chlor Alkali and Electronics markets.

  • CapEx plan is under review and will be updated in March 2025, with flexibility to adjust investment intensity based on hydrogen demand.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
All investor relations material. One API.
Learn more